Many newer biologics cost more than $100,000 per year and account for nearly 30 percent of all U.S. drug spending. For decades they have not faced generic competition because the FDA lacked a system to approve cheaper versions.
Many health workers in malaria endemic countries usually treat patients based on their signs and...
The Danish drugmaker is opening new factories in North Carolina and Denmark to keep up with...
For example, Las Vegas could become one of the largest medical marijuana markets in the country because Nevada allows dispensaries to sell to patients from other states. The city's 42 million annual visitors could create a 459,000-pound demand.
A combination of the two companies would create one of the world's largest makers of generic and over-the-counter medications.
The data could help health officials identify pockets of unvaccinated children.
Mayne Pharma will invest $65 million to expand its large-scale oral dose manufacturing capabilities and contract services.
Repatha is priced slightly below a similar drug, Praluent, which costs $14,600 per year. Analysts estimate eight to 10 million patients are covered under the FDA-approved labeling for the drugs.
The Kimtech Pure A7 Cleanroom Lab Coat from Kimberly-Clark provides enhanced chemical and biological protection and superior contamination control for cleanroom environments.
Limited access to sodium thiopental has led some states to use a one-drug mix that has been met with varying legal rulings.
The research team sought to determine if the probiotic Lactobacillus rhamnosus GG could prevent gastrointestinal colonization of multi-drug resistant organisms.
One analyst is forecasting that the economy will slow its growth to around 2.8 percent in the current quarter, but accelerate in the October-December period as long as the recent market turbulence does not inflict long-lasting damage.
The studies tried to compare the impact of cannabis (marijuana) on brain development in varying sub-sets.
The agreement centers around a RedHill drug candidate targeting the treatment of bacterial infections - a global market estimated at about $4.8 billion. Recipharm will supply the remaining clinical trial material and ongoing future commercial supply.
Chronic pain affects approximately 100 million people in the U.S. More aggressive chronic pain management with opioid analgesics over the past two decades has been associated with an increase in addiction and overdose deaths.
So far, Ram Kamath is the only one of the 14 individuals and companies facing criminal smuggling, conspiracy and money laundering charges to appear in court.
The suit says there's no guarantee Mississippi can mix a safe and effective anesthetic to knock out prisoners, and even then, prisoners could remain conscious during execution.
A U.S. District Court ruled in Lilly's favor regarding the infringement of a vitamin regimen patent for Alimta. The defendant in the case was a subsidiary of generic drugmaker Teva Pharmaceutical.